Mutant T

Natural health product licensed in Canada

Other names: MUTANT HARDCORE T, MUTANT MEGA T, MUTANT MUSCLE T, MUTANT PRIMAL T, MUTANT T +, MUTANT T HARDCORE, MUTANT T-18, MUTANT T-BLAST, MUTANT T-MAX, MUTANT T-REX, MUTANT T18, MUTANT TITAN, NORTH COAST NATURALS T, NORTH COAST NATURALS T +, PVL T, PVL T +
Licence holder: Fit Foods LP
NPN or DIN-HM: 80115924
Status: Active licence
Licence date: 27 January 2022
Revision date: 21 October 2026
Form: Capsule
Route of administration: Orale
Application type: Générale (non traditionelle)

If this product were sold in France

Dose déclarée au-delà d'une limite
Vitamine B6: up to 12 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
Dose déclarée au-delà d'une limite
Sélénium: up to 100.002 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Avena sativa Source : Graine	33.3 mg	Not calculated
Reynoutria japonica Source : Racine et rhizome Potency : 50 % resveratrol	11.67 mg	Not calculated
(2S)-7-[[6-O-(6-Déoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-méthoxyphényl)-4H-1-benzopyrane-4-one Source : Citrus sinensis - fruit	11.67 mg	Not calculated
1-[(2E, 4E)-5-(1,3-Benzodioxole-5-yl)-1-oxo-2,4-pentadiényl] pipéridine Source : Piper nigrum - fruit	0.83 mg	Not calculated
Trigonella foenum-graecum Source : Graine Extract : Matériel brut sec Extraction ratio : 10.002:1 Dry plant equivalent : 1,667 mg Potency : 50 % Saponins	166.67 mg	Not calculated
Lepidium meyenii Source : Racine	20.83 mg	Not calculated
Acide D-aspartique Source : Acide D-aspartique	250 mg	Not calculated
Vitamine B6 Source : Chlorhydrate de pyridoxine	2 mg	12,000 µg
Sélénium Source : Selemethionine	16.667 mcg	100.002 µg

Non-medicinal ingredients

Cellulose microcristalline, Stéarate de magnésium, Eau purifiée, Silicate de calcium, Hypromellose, Acide D-malique, Dextrose, Croscarmellose de sodium, Dioxyde de silicium, Carboxyméthyl cellulose de sodium, hydrolysée par action enzymatique, Oxyde de magnésium, Acide stéarique, Poudre d'enveloppes d'Oryza sativa (Riz)

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	Not specified	3 Capsule	2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Fenugreek is used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels A factor in the maintenance of good health and normal growth and development. Helps in energy metabolism and in tissue formation. Helps to maintain (proper) muscle function. Helps to maintain immune function. Source of/An antioxidant. Used in Herbal Medicine to help improve mental and/or physical performance after periods of mental and/or physical exertion. A factor in the maintenance of good health and normal growth and development. Helps in energy metabolism and in tissue formation. Helps to maintain (proper) muscle function. Helps to maintain immune function. Source of/An antioxidant.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.